Ironwood Pharmaceuticals Inc IRWD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:20 PM EDT
13.38quote price arrow down-0.03 (-0.26%)
Volume
362,231
52 week range
8.78 - 14.27
Loading...
  • Open13.39
  • Day High13.44
  • Day Low13.22
  • Prev Close13.41
  • 52 Week High14.27
  • 52 Week High Date08/12/21
  • 52 Week Low8.78
  • 52 Week Low Date02/26/21

Key Stats

  • Market Cap2.179B
  • Shares Out162.90M
  • 10 Day Average Volume1.53M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change17.56

KEY STATS

  • Open13.39
  • Day High13.44
  • Day Low13.22
  • Prev Close13.41
  • 52 Week High14.27
  • 52 Week High Date08/12/21
  • 52 Week Low8.78
  • 52 Week Low Date02/26/21
  • Market Cap2.179B
  • Shares Out162.90M
  • 10 Day Average Volume1.53M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change17.56

RATIOS/PROFITABILITY

  • EPS (TTM)3.12
  • P/E (TTM)4.29
  • Fwd P/E (NTM)10.30
  • EBITDA (TTM)224.064M
  • ROE (TTM)214.30%
  • Revenue (TTM)413.02M
  • Gross Margin (TTM)99.78%
  • Net Margin (TTM)123.20%
  • Debt To Equity (MRQ)86.37%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ironwood Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company. The Company is focused on the development and commercialization of GI product opportunities in areas of unmet need, including irritable bowel syndrome with constipation (IBS C), and chronic idiopathic constipation (CIC). It operates in human therapeutics business segment. Its product candidate LINZESS (linaclotide) is available to adult men and women suffering from IBS-C or CIC in the United States...
Julie Mchugh
Chairman
Thomas McCourt
President
Jason Rickard
Chief Financial Officer
Ronald Silver
Chief Accounting Officer
Address
100 Summer St Ste 2300
Boston, MA
02110-2156
United States

Top Peers

SYMBOLLASTCHG%CHG
CORT
Corcept Therapeutics Inc
19.70+0.74+3.90%
PCRX
Pacira Biosciences Inc
52.60-0.48-0.90%
HRMY
Harmony Biosciences Holdings Inc
43.40+5.37+14.12%
AMRN
Amarin Corporation PLC
5.09+0.06+1.09%
HSKA
Heska Corp
254.02+2.04+0.81%